Investigates miRNA dysregulation in cancer. OncomiR is composed of three distinct parts: (1) a database of statistically dysregulated miRNAs associated with clinical characteristics of cancer; (2) miRNA-target expression correlation and determination across cancer types; and (3) tools for dynamic study of miRNA-derived survival signatures and clustering of cancer types. It assists users to understand the involvement of miRNAs in cancer progression.
Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO, USA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA; Department of Electrical and Systems Engineering, Washington University in St. Louis, St. Louis, MO, USA
OncomiR funding source(s)
Supported by the National Institutes of Health [Grants R01GM089784 and R01DE026471].